Ana Baños

485 total citations
15 papers, 301 citations indexed

About

Ana Baños is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Ana Baños has authored 15 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Nephrology. Recurrent topics in Ana Baños's work include Nausea and vomiting management (3 papers), Anesthesia and Pain Management (3 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Ana Baños is often cited by papers focused on Nausea and vomiting management (3 papers), Anesthesia and Pain Management (3 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Ana Baños collaborates with scholars based in United States, Switzerland and United Kingdom. Ana Baños's co-authors include René Hornung, Martin Wolf, Bastian Dehmel, Alexandre Chan, Shiying Yu, Dorothy Keefe, Thomas Burke, Ingrid Os, Denis Fouque and Neil Ashman and has published in prestigious journals such as American Journal of Kidney Diseases, Nephrology Dialysis Transplantation and BMC Cancer.

In The Last Decade

Ana Baños

15 papers receiving 286 citations

Peers

Ana Baños
Ana Baños
Citations per year, relative to Ana Baños Ana Baños (= 1×) peers Lida Tartaglione

Countries citing papers authored by Ana Baños

Since Specialization
Citations

This map shows the geographic impact of Ana Baños's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Baños with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Baños more than expected).

Fields of papers citing papers by Ana Baños

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Baños. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Baños. The network helps show where Ana Baños may publish in the future.

Co-authorship network of co-authors of Ana Baños

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Baños. A scholar is included among the top collaborators of Ana Baños based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Baños. Ana Baños is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ariceta, Gema, Laure Collard, Saoussen Abroug, et al.. (2022). ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. Pediatric Nephrology. 38(2). 403–415. 13 indexed citations
2.
Milliner, Dawn S., Pierre Cochat, Sally‐Anne Hulton, et al.. (2021). Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies. Pediatric Nephrology. 36(7). 1785–1793. 13 indexed citations
3.
Höppe, Bernd, et al.. (2020). Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study. Nephrology Dialysis Transplantation. 36(8). 1464–1473. 29 indexed citations
4.
Kim, Hoon-Kyo, Ruey-Kuen Hsieh, Alexandre Chan, et al.. (2014). Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Supportive Care in Cancer. 23(1). 293–300. 16 indexed citations
5.
Chan, Alexandre, Hoon-Kyo Kim, Ruey Kuen Hsieh, et al.. (2014). Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice—a longitudinal analysis. Supportive Care in Cancer. 23(1). 283–291. 31 indexed citations
7.
Thaler, Josef, Meinolf Karthaus, Laurent Mineur, et al.. (2012). Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study. BMC Cancer. 12(1). 438–438. 31 indexed citations
8.
Hornung, René, et al.. (2010). Frequency-domain near-infrared spectroscopy of the uterine cervix during regular pregnancies. Lasers in Medical Science. 26(2). 205–212. 16 indexed citations
9.
Baños, Ana, et al.. (2009). The effects of discontinuing cinacalcet at the time of kidney transplantation. Clinical Kidney Journal. 3(1). 37–41. 8 indexed citations
10.
Wolf, Martin, et al.. (2009). Optical properties of the breast during spontaneous and birth control pill-mediated menstrual cycles. Lasers in Medical Science. 24(6). 901–907. 7 indexed citations
11.
Ureña, Pablo, Stefan H. Jacobson, Emanuel Zitt, et al.. (2009). Cinacalcet and achievement of the NKF/K-DOQITM recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study. Nephrology Dialysis Transplantation. 24(9). 2852–2859. 84 indexed citations
12.
Wolf, Martin, et al.. (2008). Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers in Medical Science. 24(4). 561–566. 9 indexed citations
13.
Baños, Ana, et al.. (2007). Frequency domain near‐infrared spectroscopy of the uterine cervix during cervical ripening. Lasers in Surgery and Medicine. 39(8). 641–646. 17 indexed citations
14.
Floege, Jürgen, et al.. (2007). 60. American Journal of Kidney Diseases. 49(4). B39–B39. 1 indexed citations
15.
Frazão, João, Piergiorgio Messa, John Cunningham, et al.. (2006). Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism. Digital Access to Libraries. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026